AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00401089 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Panax Ginseng
Description: The standardized extract of Panax Ginseng was formulated by Boehringer Ingelheim Pharmaton, Switzerland and fulfills the criteria of cGMP. Quality control and safety are monitored regularly by Boehringer Ingelheim Pharmaton.
Study NCT00401089 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Panax Ginseng
Description: The standardized extract of Panax Ginseng was formulated by Boehringer Ingelheim Pharmaton, Switzerland and fulfills the criteria of cGMP. Quality control and safety are monitored regularly by Boehringer Ingelheim Pharmaton.
Study NCT03700944 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yoga training
Description: Complete protocol with yoga training for a period of 8 weeks, 60 minutes, 3 times a week.
Study NCT02254174 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tiotropium/Salmeterol
Description: Fixed dose combination of tiotropium 7.5 μg and salmeterol 25 μg inhalation powder, PE capsule via HandiHaler®
Study NCT02254174 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Serevent® Diskus®
Study NCT02254174 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Spiriva®
Study NCT01196260 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine and Oxaliplatin
Description: Capecitabine and Oxaliplatin will be under the NSCLC guideline
Study NCT02149745 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Calling the patient's name
Description: calling the patient's name during anesthesia reversal
Study NCT02149745 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Not calling the patient's name
Description: giving verbal stimulus other than the patient's name during anesthesia reversal
Study NCT03257722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Anti PD-1 immunotherapeutic agent, which blocks a protective mechanism on cancer cells to allow the immune system to destroy cancer cells. Administered intravenously (IV).
Study NCT03257722 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Idelalisib
Description: Phosphatidylinositol 3-kinase (PI3K) inhibitor which promotes anti-tumor immune response. Administered orally (PO).
Study NCT01311245 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stage-tailored intervention
Description: Based on the Trans-Theoretical Model of intentional behavior change (TTM). According to their stage of change, participants received two computer generated feedback letters on their risky drinking, stage of change, processes of change, self-efficacy, and decisional balance. The first letter included normative feedback (interpersonal comparison with other individuals in the same stage), and was sent out by mail after baseline. The second letter included normative and ipsative feedback (intrapersonal comparisons: baseline vs. 3 months later), and was sent out by mail three months later.
Study NCT01311245 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Non-stage-tailored Intervention
Description: Based on the Theory of Planned Behavior (TPB). Participants received two computer generated feedback letters on their risky drinking, beliefs (behavioral, normative, control), attitude, subjective norm, perceived behavioral control, intention, and they were asked to fill in a where-when-how to change plan. The first letter included normative feedback (interpersonal comparison with other women/ men), and was sent out by mail after baseline. The second letter included normative and ipsative feedback, and was sent out by mail three months later.
Study NCT03502161 — intervention group
Intervention type: DEVICE
Intervention: QuantiFERON CMV Assay
Description: Assay to measure cell-mediated immune function using QuantiFERON CMV assay.
Study NCT03748953 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ixazomib
Description: Ixazomib Capsules
Study NCT03539003 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sevoflurane
Description: anesthesia was induced with propofol (1.5 mg/kg) and target controlled infusion (TCI) of remifentanil (2-3 ng/mL of targeted effect site concentration (Ce). After intubation, inspired concentration of sevoflurane (0.8-1 MAC) and the Ce of remifentanil TCI (1.0-2.0 ng/ml) were adjusted to a BIS target level for hypnosis of 40-60 during surgery.
Study NCT02841878 — intervention group
Intervention type: GENETIC
Group type: OTHER
Intervention: Analysis on colorectal biopsy
Study NCT03588962 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: In-stent restenosis
Description: Patch tests for the metals applicated in each of the patients
Study NCT03588962 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: In-stent restenosis
Description: Patch tests for the metals applicated in each of the patients
Study NCT01662648 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paliperidone ER
Description: Paliperidone extended-release (ER) tablet in dose range of 3 to 12 milligram (mg) per day will be given orally for 6 months as per Investigator's discretion.
Study NCT02905734 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Description: Single administration of an active treatment (nicotine patch)
Study NCT02905734 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo patch
Description: Single administration of a placebo treatment
Study NCT02773966 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Kypho-IORT
Description: During kyphoplasty/vertebroplasty a intraoperative radiotherapy of the affected vertebrae is done with a miniature X-ray generator (INTRABEAM®, Carl Zeiss, Surgical, Oberkochen, Germany). The prescription dose will be 8 Gy in a distance of 13 mm from the isocenter of the radiation source. IORT will take about five minutes. After radiation the applicator will be removed and the operation will be finished as usual.
Study NCT02773966 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: EBRT
Description: The external beam radiotherapy will be usually carried out as an outpatient procedure. All patients will receive a planning CT before the first irradiation. EBRT will be performed with 30 Gy, added in 3 Gy per fraction or 8 Gy single dose (only for international study centers, not permitted in Germany) on a conventional linear accelerator (LINAC).
Study NCT00953394 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: continuous 5 fluouracil infusion plus long-acting octreotide
Description: long-acting octreotide acetate at a dose of 20 mg was administered intramuscularly every 4 weeks. 5fluorouracil was given as a protracted continuous infusion without interruption at a daily dose of 200 mg/m2 of body-surface area through an elastomeric pump connected to a central venous access.
Study NCT00755079 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: extended release beta-2 adrenergic agonist
Description: Albuterol extended release belongs to a class of drugs known as bronchodilators. It works in the airways by opening breathing passages and relaxing muscles.
Study NCT00755079 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: An ambiguous sheathing capsule will be placed over a lactose placebo pill. The placebo will have no effect on pulmonary function.
Study NCT00630045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: neoadjuvant chemotherapy with oxaliplatin and capecitabine
Description: oxaliplatin: 130mg/m2, d1(Q3w) capecitabine:1000mg/m2 bid, d1-14(Q3w)
Study NCT00630045 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: resection of liver metastasis
Description: surgery with the aim of R0 resection
Study NCT00630045 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: resection of liver metastasis
Description: surgery with the aim of R0 resection
Study NCT03527576 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Intravenous injection of 0.15 mg/kg of dexamethasone before the surgery.
Study NCT03527576 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: NaCl 0.0308 MEQ/ML Injectable Solution
Description: Intravenous injection of NaCl 0.9% before the surgery.
Study NCT00899652 — intervention group
Intervention type: GENETIC
Intervention: Southern blotting
Study NCT00899652 — intervention group
Intervention type: GENETIC
Intervention: chromosomal translocation analysis
Study NCT00899652 — intervention group
Intervention type: GENETIC
Intervention: cytogenetic analysis
Study NCT00899652 — intervention group
Intervention type: GENETIC
Intervention: gene rearrangement analysis
Study NCT00899652 — intervention group
Intervention type: GENETIC
Intervention: mutation analysis
Study NCT00868790 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-3577
Description: MK-3577 oral tablets totaling 6 mg in the evening (PM), 10 mg in the morning (AM), or 25 mg twice daily (BID) depending upon randomization, administered during a 4 week treatment period.
Study NCT01850927 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Remote ischaemic preconditioning
Study NCT01850927 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Control
Study NCT04054947 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Suicide Prevention Program
Description: Structured care management to improve adherence to discharge planning.
Study NCT03067233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Polysomnography
Description: Complete polysomnography with : Electroencephalogry, electro-oculography, surface electromyography (chin muscle, anterior tibial muscles), nasal pressure, respiratory movements (plethysmography of thoracic and abdominal inductance), pulse oximetry and electrocardiography.
Study NCT01337102 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Physician Receives QoL results
Description: Patient completes the Lung Cancer QoL scale on the Palm held computer device and the Physician receives the print out of the results.
Study NCT01337102 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Physician Does not receive the results
Description: Patient completes the Lung Cancer QoL scale on the Palm held computer device and the Physician does not receive the print out of the results.
Study NCT03570463 — intervention group
Intervention type: BEHAVIORAL
Intervention: GLA:D Back
Description: The intervention aims at improving the participant's ability to self-manage low back pain (LBP). The content is based on a cognitive behavioural approach aimed at supporting pain self-efficacy. An individual session at the beginning and the end of the group sessions involve goal-setting and physical tests. Key messages of the patient education include that pain is not a sign of danger and back pain is explained using a behavioural model of (im)balance between demands and capacity rather than emphasising tissue damage. The exercises aim at restoring natural variation in movement and provides guidance for patients in exploring movement rather than teaching exercises in only one correct manner.
Study NCT04643600 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: L-Arginine, 500 Mg Oral Capsule
Description: The strength test of the the quadriceps muscle, will be measured in all patients on the Biodex isokinetic device. Quadriceps strength testing will be performed on 2 occasions. On one occasion without medication, except those that the patient may take permanently, and on the other 90 minutes after the patient takes 1 tbl of L - Arginine 500 mg on mouth to an empty stomach ,in order to monitor the possible increase in quadriceps strength.
Study NCT01227629 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dabigatran with ASA
Description: dose comparison in combination
Study NCT01227629 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: warfarin
Description: comparator
Study NCT01227629 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dabigatran without ASA
Description: dose comparison
Study NCT04176601 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Engage coaching
Description: Participants will complete up to 8 weekly individual Social Engage psychotherapy sessions. Participants will be allotted up to 3 months to complete all sessions, a time-frame that allows for two weeks without meeting to address life stressors such as illnesses that may pop up. All sessions are provided via phone or videocall (Zoom). The first and last session are longer - up to 60 minutes if needed. Middle sessions are shorter (20-45 minutes). Engage is a stepped care psychotherapy in that the simplest strategy is taught first-action planning (a derivative of problem solving therapy)-and barrier strategies are added only if needed. Action plans are designed to address loneliness and social isolation in the context of caregiving demands.
Study NCT03753581 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Care protocol plus microcurrents
Description: CARE NURSING PROTOCOL: postural treatment every 4 hours more standardized cure according to the guide of recommendations based on evidence in prevention and treatment of pressure ulcers in adults of Osakidetza health service.~MICROCURRENTS: the electrodes will be placed on the edge of the dressing on the sides of the ulcer's longer length during 12 hours a day until the ulcer is completely healed or for a maximum of 25 days.~Characteristics of microcurrents: pulsed monophasic rectangular wave with a pulse of 1.5 s and pause of 300 ms, voltage 21 mV and intensity 42μA with a current density of 4.2 μA.
Study NCT03753581 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Care protocol plus placebo microcurrents
Description: The same nursing care protocol described for the experimental group will be applied more 12 hours per day of 2 electrodes of microcurrents around the ulcer, which will be previously manipulated and tested with an oscilloscope so that they do not emit electrical currents
Study NCT03539003 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: desflurane
Description: anesthesia was induced with propofol (1.5 mg/kg) and target controlled infusion (TCI) of remifentanil (2-3 ng/mL of targeted effect site concentration (Ce). After intubation, inspired concentration of desflurane (0.8-1 MAC) and the Ce of remifentanil TCI (1.0-2.0 ng/ml) were adjusted to a BIS target level for hypnosis of 40-60 during surgery.
Study NCT03539003 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: propofol and remifentanil
Description: anesthesia was induced with an effect-site concentration of 3-4 μg/ml propofol and 2-3 ng/ml remifentanil using target-controlled infusion (TCI). After intubation, The effect site TCI of propofol (2-3 μg/ml) and remifentanil (1.0-2.0 ng/ml) was adjusted to maintain the desired hypnosis (40-60 of the BIS value) during surgery.
Study NCT00904553 — intervention group
Intervention type: RADIATION
Intervention: Novalis Shaped Beam Surgery
Description: Treatment using Novalis SRS
Study NCT00162474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Warfarin
Study NCT00162474 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenytoin
Study NCT01674166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prucalopride
Description: single dose 0.03 mg/kg prucalopride open label
Study NCT01846585 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Arousal Based Therapy for Insomnia
Description: Intervention includes education about sleep and a desensitization technique to reduce sleep interfering arousal
Study NCT01846585 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: Intervention includes education about sleep and behavioral and cognitive strategies to improve sleep
Study NCT02273622 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: hydroxytyrosol
Description: Pilot study with 20 participants, each participant will alternately by the two arms of the study (hydroxytyrosol 5 mg and 20 mg) and control, during 6 weeks.
Study NCT02273622 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Study NCT01773330 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: esophageal manometry
Description: Esophageal manometry will be performed by swallowing different amounts of Gatorade depending on the protocol being followed.There will be alternate assignment of positions: supine position, semi-recumbent position,sitting position and standing up position.
Study NCT01773330 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Gatorade
Description: The patient will be given Gatorade to drink at various times during the study.
Study NCT01773330 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Supine position
Description: Esophageal manometry will be performed by swallowing different amounts of Gatorade depending on the protocol being followed. There will be alternate assignment of positions: supine position, semi-recumbent position,sitting position and standing up position.
Study NCT01773330 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Semi-recumbent position
Description: Esophageal manometry will be performed by swallowing different amounts of Gatorade depending on the protocol being followed. There will be alternate assignment of positions: supine position, semi-recumbent position,sitting position and standing up position.
Study NCT01773330 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sitting
Description: Esophageal manometry will be performed by swallowing different amounts of Gatorade depending on the protocol being followed. There will be alternate assignment of positions: supine position, semi-recumbent position,sitting position and standing up position.
Study NCT01773330 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standing
Description: Esophageal manometry will be performed by swallowing different amounts of Gatorade depending on the protocol being followed. There will be alternate assignment of positions: supine position, semi-recumbent position,sitting position and standing up position.
Study NCT01548248 — intervention group
Intervention type: DRUG
Intervention: insulin detemir
Description: Prescribed insulin detemir and insulin aspart based on the clinical judgement of the physician. The insulin preparations were prescribed by the physician solely as a result of a normal clinical evaluation. The physician determined the starting dose and frequency, as well as later changes to either dose or frequency, if any.
Study NCT01548248 — intervention group
Intervention type: DRUG
Intervention: insulin aspart
Description: Prescribed insulin detemir and insulin aspart based on the clinical judgement of the physician. The insulin preparations were prescribed by the physician solely as a result of a normal clinical evaluation. The physician determined the starting dose and frequency, as well as later changes to either dose or frequency, if any.
Study NCT02543203 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Reconnect
Description: Topical Essential Oils mixture and aromatic method
Study NCT02543203 — intervention group
Intervention type: BIOLOGICAL
Group type: SHAM_COMPARATOR
Intervention: Reconnect
Description: Topical Essential Oils mixture and aromatic method
Study NCT02543203 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Coconut oil Comparator
Description: Topical Essential Oils mixture and aromatic method
Study NCT02543203 — intervention group
Intervention type: BIOLOGICAL
Group type: SHAM_COMPARATOR
Intervention: Coconut oil Comparator
Description: Topical Essential Oils mixture and aromatic method
Study NCT02832752 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ECPR Protocol
Description: The regional protocol is activated for eligible patients who remain pulseless after 3 cycles of resuscitation, and intubation. The hospital team is activated at this time, which includes the emergency department team, a perfusionist, and a cardiovascular surgeon. A mechanical CPR device (Lucas chest compression device) is applied at this time and the patient is transported to hospital. The goal times from first professional CPR to ECMO flows is \< 60 minutes, and from emergency department (ED) arrival to ECMO flows \< 30 minutes.
Study NCT02185872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High-Intensity Functional Training
Description: Participants were instructed to work as hard as they could while maintaining safe technique and proper form to achieve as many reps or rounds as possible in the prescribed time frame. As HIFT participants became accustomed to specific movements, less time was dedicated to practicing movements and technique.
Study NCT02185872 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Aerobic and Resistance Training
Description: The protocol was based upon current guidelines of 150 minutes moderate-intensity aerobic activity and 2 days of muscle strengthening per week.
Study NCT00724191 — intervention group
Intervention type: PROCEDURE
Intervention: MRI
Description: New MRI methods which measure information related to water, blood, and chemical makeup in the brain.
Study NCT00949585 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Dietary intake of potassium
Description: Comparison of two diets: one contains 100 mmol potassium per day, and the other contains 40 mmol potassium per day